Amisulpride is a benzamide derivative and a dopamine receptor antagonist that selectively works on dopamine D2 and D3 receptors. As an antipsychotic agent, amisulpride alleviates both positive and negative symptoms of schizophrenia, and it exhibits antidepressant properties in patients with psychiatric disorders, dysthymia, and major depression. It is grouped under the following drug class(es): Psychotropic agents and QTc-prolonging agents. Its therapeutic use is listed as antipsychotics and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Deniban, Amisulprida, Solian, Aminosultopride and Barhemsys. Its PubChem CID is 2159.
Amisulpride
| CAS No | 71675-85-9 |
|---|---|
| Molecular Formula | C17H27N3O4S |
| Molecular Weight | 369.48 g/mol |
| Synonyms | 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Amisulpride is a benzamide derivative and a dopamine receptor antagonist that selectively works on dopamine D2 and D3 receptors.
The listed CAS number is 71675-85-9.
The listed molecular formula is C17H27N3O4S.
The listed molecular weight is 369.48 g/mol.
4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide.
The source lists Deniban, Amisulprida, Solian, Aminosultopride and Barhemsys.